{"title":"Global and regional prevalence of osteoporosis in kidney transplant recipients: a systematic review and meta-analysis.","authors":"Mobin Ghazaiean, Tahoora Mousavi, Mahmood Moosazadeh","doi":"10.1007/s10238-025-01716-w","DOIUrl":null,"url":null,"abstract":"<p><p>Kidney transplant recipients (KTRs) are at a heightened risk of low bone density and fractures. This study sought to determine the overall prevalence of osteoporosis in KTRs. Published observational studies and those with a baseline report on osteoporosis were evaluated in databases such as PubMed, Scopus, Science Direct, Web of Science, and EMBASE, in addition to Google Scholar from January 1, 2000, to January 1, 2024. The methodological quality of the included studies was rigorously assessed using the JBI Critical Appraisal checklist. Heterogeneity across primary study results was evaluated using the I-square index, while publication bias was scrutinized using Egger's test and funnel plots. Statistical analyses were carried out using Stata software Ver. 11. After conducting searches across multiple databases, a total of 136 primary studies were ultimately included. The prevalence of osteoporosis in specific skeletal areas is as follows: 20% (95% CI 18-23, n = 67) in the lumbar region, 23% (95% CI 19-26, n = 53) in the femoral neck, 15% (95% CI 11-19, n = 20) in the total hip, 29% (95% CI 10-49, n = 5) in the forearm, and 34% (95% CI 28-40, n = 6) in the ultradistal radius. Based on sex-specific rate in the existing literature, the prevalence is reported as 21% (95% CI 15-27, n = 16) in men and 28% (95% CI 20-35, n = 16) in women. Our results for adult KTRs represent the high prevalence of osteoporosis which was highest in bone site rich in cortical content (e.g., ultradistal radius).</p>","PeriodicalId":10337,"journal":{"name":"Clinical and Experimental Medicine","volume":"25 1","pages":"214"},"PeriodicalIF":3.5000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181100/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10238-025-01716-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Kidney transplant recipients (KTRs) are at a heightened risk of low bone density and fractures. This study sought to determine the overall prevalence of osteoporosis in KTRs. Published observational studies and those with a baseline report on osteoporosis were evaluated in databases such as PubMed, Scopus, Science Direct, Web of Science, and EMBASE, in addition to Google Scholar from January 1, 2000, to January 1, 2024. The methodological quality of the included studies was rigorously assessed using the JBI Critical Appraisal checklist. Heterogeneity across primary study results was evaluated using the I-square index, while publication bias was scrutinized using Egger's test and funnel plots. Statistical analyses were carried out using Stata software Ver. 11. After conducting searches across multiple databases, a total of 136 primary studies were ultimately included. The prevalence of osteoporosis in specific skeletal areas is as follows: 20% (95% CI 18-23, n = 67) in the lumbar region, 23% (95% CI 19-26, n = 53) in the femoral neck, 15% (95% CI 11-19, n = 20) in the total hip, 29% (95% CI 10-49, n = 5) in the forearm, and 34% (95% CI 28-40, n = 6) in the ultradistal radius. Based on sex-specific rate in the existing literature, the prevalence is reported as 21% (95% CI 15-27, n = 16) in men and 28% (95% CI 20-35, n = 16) in women. Our results for adult KTRs represent the high prevalence of osteoporosis which was highest in bone site rich in cortical content (e.g., ultradistal radius).
肾移植受者(KTRs)低骨密度和骨折的风险较高。本研究旨在确定ktr中骨质疏松症的总体患病率。从2000年1月1日至2024年1月1日,在PubMed、Scopus、Science Direct、Web of Science和EMBASE等数据库以及谷歌Scholar中对已发表的观察性研究和骨质疏松基线报告进行了评估。纳入研究的方法学质量使用JBI关键评估清单进行严格评估。主要研究结果的异质性使用i平方指数进行评估,而发表偏倚使用Egger检验和漏斗图进行审查。采用Stata软件进行统计分析。在多个数据库中进行搜索后,最终纳入了136项主要研究。骨质疏松症在特定骨骼区域的患病率如下:20% (95% CI 18-23, n = 67)在腰椎区,23% (95% CI 19-26, n = 53)在股骨颈,15% (95% CI 11-19, n = 20)在全髋,29% (95% CI 10-49, n = 5)在前臂,34% (95% CI 28-40, n = 6)在桡骨超远端。根据现有文献中不同性别的发病率,男性患病率为21% (95% CI 15-27, n = 16),女性患病率为28% (95% CI 20-35, n = 16)。我们对成人ktr的研究结果表明,骨质疏松症的高患病率在皮质含量丰富的骨骼部位(如桡骨超远端)最高。
期刊介绍:
Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology. The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies. Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance. Case reports will be accepted on an exceptional basis only, and their submission is discouraged. The major criteria for publication are clarity, scientific soundness, and advances in knowledge. In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.